Francesco Rettura

Cosenza, 87100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study.

Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study.

Journal: Nutrients

Published: February 19, 2026

Targeting γ-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis.

Targeting γ-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis.

Journal: Frontiers in pharmacology

Published: July 31, 2025

Evaluation of a Modified London Protocol to Diagnose Defecation Disorders With High-Definition Anorectal Manometry.

Evaluation of a Modified London Protocol to Diagnose Defecation Disorders With High-Definition Anorectal Manometry.

Journal: Neurogastroenterology and motility

Published: July 13, 2025

Rome Constipation Symptoms Augmented by Painful Defecation Predicts Specific Subtypes of Refractory Constipation.

Rome Constipation Symptoms Augmented by Painful Defecation Predicts Specific Subtypes of Refractory Constipation.

Journal: Neurogastroenterology and motility

Published: April 29, 2025

Gut Virome: What's the Role in Irritable Bowel Syndrome?

Gut Virome: What's the Role in Irritable Bowel Syndrome?

Journal: Reviews in medical virology

Published: April 10, 2025

Mucoprotectants and gut barrier: mechanisms of action and clinical applications in IBS. Is there a possible role?

Mucoprotectants and gut barrier: mechanisms of action and clinical applications in IBS. Is there a possible role?

Journal: Frontiers in pharmacology

Published: December 03, 2024

Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes.

Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes.

Journal: Nutrients

Published: September 05, 2024

Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients.

Prokineticin-2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: May 02, 2024

Gut-directed therapy in Parkinson's disease.

Gut-directed therapy in Parkinson's disease.

Journal: Frontiers in pharmacology

Published: March 27, 2024

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights.

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights.

Journal: Journal of clinical medicine

Published: August 08, 2023

Difficult defecation in constipated patients: Diagnosis by minimally invasive diagnostic tests.

Difficult defecation in constipated patients: Diagnosis by minimally invasive diagnostic tests.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 14, 2023

Role of Low-FODMAP diet in functional dyspepsia: "Why", "When", and "to Whom".

Role of Low-FODMAP diet in functional dyspepsia: "Why", "When", and "to Whom".

Journal: Best practice & research. Clinical gastroenterology

Published: March 26, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026